Correspondingly, study of the PINK1/Parkin-mediated mitophagy pathway has shown that reduced expression of PINK1 or Parkin exacerbates mitochondrial damage in NAFLD models, whereas increased mitophagy alleviates disease progression (63). This evidence concerns the gene PRKN and metabolic dysfunction-associated steatotic liver disease.